<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Myeloma Forum | peral | Activity</title>
	<link>https://forum.myeloma.org.uk/members/peral/activity/</link>
	<atom:link href="https://forum.myeloma.org.uk/members/peral/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for peral.</description>
	<lastBuildDate>Sun, 12 Apr 2026 14:12:42 +0100</lastBuildDate>
	<generator>https://buddypress.org/?v=2.9.4</generator>
	<language>en-GB</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">b42d851387eef7c54b89e9d9d4fe2c04</guid>
				<title>peral started the topic multiple pretreated and refractory .......ibrutinib? in the forum Treatment</title>
				<link>http://www.myeloma.org.uk/forums/topic/multiple-pretreated-and-refractory-ibrutinib/</link>
				<pubDate>Thu, 17 Apr 2014 14:18:12 +0100</pubDate>

									<content:encoded><![CDATA[<p>Hi there,</p>
<p>just heard from a german private clinic using ibrutinib for highly pretreated refractory MM off-label (last-line therapy) &#8211; would be great to have some feedback on ibrutinib &#8211; would this be worth it to go for?</p>
<p>Thanks for your feedback in advance,</p>
<p>peral</p>
]]></content:encoded>
				
				
							</item>
		
	</channel>
</rss>